These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24979587)

  • 1. Anaesthesia and orphan disease: a child with neuronal ceroid lipofuscinosis.
    Richa F
    Eur J Anaesthesiol; 2015 Mar; 32(3):213-5. PubMed ID: 24979587
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is myopathy with rimmed vacuoles a hallmark of juvenile neuronal ceroid lipofuscinosis (CLN3)?
    Borgione E; Castello F; Lo Giudice M; Santa Paola S; Salvatore S; Berti G; Malandrini A; Bottitta M; Musumeci SA; Scuderi C
    Neurol Sci; 2016 May; 37(5):805-7. PubMed ID: 26700800
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-Generation Sequencing in the Diagnosis of Juvenile Neuronal Ceroid Lipofuscinosis.
    Deacon BS; Charles JM; Cheeseman EW; Cathey SS
    Pediatr Neurol; 2016 Sep; 62():71-2. PubMed ID: 27215405
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 7. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course.
    Aberg L; Lauronen L; Hämäläinen J; Mole SE; Autti T
    Pediatr Neurol; 2009 Feb; 40(2):134-7. PubMed ID: 19135632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinosis with severe biventricular impairment: a rare genetic disorder with associated myopathy?
    Khanji MY; Rusinova R; Shaukat M; Sekhri N
    Eur Heart J; 2018 Jan; 39(1):74. PubMed ID: 29182766
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in multi-gene panel testing in pediatric ophthalmology.
    Turriff AE; Cukras CA; Brooks BP; Huryn LA
    J AAPOS; 2019 Jun; 23(3):163-165.e1. PubMed ID: 30769084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthesia and orphan disease: A 2-year-old with neuronal ceroid lipofuscinosis.
    Wang S; Pei L
    Eur J Anaesthesiol; 2020 Feb; 37(2):138-141. PubMed ID: 31913935
    [No Abstract]   [Full Text] [Related]  

  • 12. Epileptological aspects of juvenile neuronal ceroid lipofuscinosis (CLN3 disease) through the lifespan.
    Arntsen V; Strandheim J; Helland IB; Sand T; Brodtkorb E
    Epilepsy Behav; 2019 May; 94():59-64. PubMed ID: 30884409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?
    Albert DV; Yin H; De Los Reyes EC; Vidaurre J
    J Child Neurol; 2016 Nov; 31(13):1475-1482. PubMed ID: 27445018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Ostergaard JR; Rasmussen TB; Mølgaard H
    Neurology; 2011 Apr; 76(14):1245-51. PubMed ID: 21464428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar neuropsychiatric presentations of two siblings with juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Lee TS; Poon SH; Chang P
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E14-5. PubMed ID: 20160229
    [No Abstract]   [Full Text] [Related]  

  • 17. Late infantile neuronal ceroid lipofuscinosis: mutations in the CLN2 gene and clinical course in Spanish patients.
    Pérez-Poyato MS; Marfa MP; Abizanda IF; Rodriguez-Revenga L; Sánchez VC; González MJ; Puñal JE; Pérez AV; González MM; Bermejo AM; Hernández EM; Rosell MJ; Gort L; Milá M
    J Child Neurol; 2013 Apr; 28(4):470-8. PubMed ID: 22832778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 19. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.